BioSpace News Archive

Bruker Announces Further Progress in 4D Proteomics and Additional Novel timsTOF Pro™ Workflows at EuPA 2019

New workflows for next-generation 4D metabolomics, leveraging routine, accurate and large-scale collision cross section (CCS) determinations on timsTOF Pro

March 25, 2019
·
6 min read
Business

Ionis announces appointment of Brett P. Monia Ph.D. to its board of directors

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, announced that Brett P. Monia, Ph.D., has been appointed to the company’s board of directors.

March 25, 2019
·
2 min read
IMV Inc. to Present at Two Upcoming Investor Conferences

IMV Inc., a clinical stage immuno-oncology company, announced that IMV Chief Executive Officer Frederic Ors will present at the Spring Investor Summit and the HC Wainwright Global Life Sciences Conference during April 2019.

March 25, 2019
·
1 min read
Deals

AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

Introduced plato™ platform for worldwide gene therapy commercialization, to be incorporated in AVROBIO-sponsored clinical trials in 2019

March 25, 2019
·
13 min read
Biotech Bay

Alkahest Presents Positive Results from Phase 2a Open Label Study of AKST4290 in Treatment-Naïve neovascular AMD at Retina World Congress

Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, shared results yesterday from its open label study, ALK4290-201.

March 25, 2019
·
4 min read
Business

Epic Sciences Appoints Lloyd Sanders as Chief Executive Officer

Epic Sciences, Inc. announced that Lloyd Sanders has joined the company as president and chief executive officer.

March 25, 2019
·
3 min read
Business

Front Range Biosciences® Announces International Partnership with the Centre for Research in Agricultural Genomics

Company’s Arrival in Europe Facilitates Global Cooperation in Agricultural Technology

March 25, 2019
·
3 min read
Drug Development

Avanir Pharmaceuticals, Inc. Reports Phase 3 Data Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer’s Dementia

Avanir Pharmaceuticals, Inc. announced today the results from the first study of the company’s phase 3 clinical development program investigating the efficacy, safety and tolerability of AVP-786 for the treatment of moderate-to-severe agitation in patients with Alzheimer’s dementia.

March 25, 2019
·
7 min read
Genetown

TraceLink Announces FutureLink Nashville in October 2019

TraceLink Inc., the world’s largest integrated digital supply network providing real-time information sharing for better patient outcomes, announced its second FutureLink event this year, to be held in Nashville from October 2-4, 2019.

March 25, 2019
·
2 min read
Pharm Country

Statement from Foundation Consumer Healthcare, maker of St. Joseph® Low Dose Aspirin, on recent ACC/AHA guidelines for prevention of cardiovascular disease

As the maker of St. Joseph 81 mg low dose aspirin, a brand with a 125-year heritage as America’s original aspirin, Foundation Consumer Healthcare stands behind the available evidence supporting the use of an aspirin regimen for secondary prevention of a heart attack or stroke.

March 25, 2019
·
2 min read